Nirlus Overview

  • Founded
  • 2006
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 1

Nirlus General Information


Developer of devices designed to offer non-invasive blood glucose monitoring services. The company's devices use technologies for non-invasive analysis of chemical compositions of human blood, enabling patients to improve their health and well-being by being able to monitor blood sugar levels frequently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • Salzwiese 3
  • 23560 Lübeck
  • Germany
+49 0451 00000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nirlus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Jan-2012 Completed Generating Revenue
To view Nirlus’s complete valuation and funding history, request access »

Nirlus Executive Team (2)

Name Title Board Seat Contact Info
Andrej Augustinov Co-Founder & Co-Chairman
Vera Herrmann Ph.D Co-Founder & Board Member
To view Nirlus’s complete executive team members history, request access »

Nirlus Board Members (5)

Name Representing Role Since
Andre Hoffmann Nirlus Board Member 000 0000
Andrej Augustinov Nirlus Co-Founder & Co-Chairman 000 0000
Ernst Peter Komrowski Nirlus Board Member 000 0000
Hannes Fehr Nirlus Co-Chairman 000 0000
Vera Herrmann Ph.D Nirlus Co-Founder & Board Member 000 0000
To view Nirlus’s complete board members history, request access »

Nirlus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EMBL Ventures Venture Capital Minority 000 0000 000000 0
To view Nirlus’s complete investors history, request access »